Legal & General Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.7K | Sell |
|
|||||
|
2025
Q2 | $175K | Sell |
|
|||||
|
2025
Q1 | $818K | Buy |
|
|||||
|
2024
Q4 | $948K | Buy |
|
|||||
|
2024
Q3 | $1.24M | Buy |
|
|||||
|
2024
Q2 | $1.44M | Buy |
|
|||||
|
2024
Q1 | $1.78M | Sell |
|
|||||
|
2023
Q4 | $1.99M | Buy |
|
|||||
|
2023
Q3 | $1.17M | Buy |
|
|||||
|
2023
Q2 | $1.08M | Buy |
|
|||||
|
2023
Q1 | $922K | Buy |
|
|||||
|
2022
Q4 | $798K | Buy |
|
|||||
|
2022
Q3 | $568K | Sell |
|
|||||
|
2022
Q2 | $536K | Buy |
|
|||||
|
2022
Q1 | $471K | Sell |
|
|||||
|
2021
Q4 | $650K | Buy |
|
|||||
|
2021
Q3 | $887K | Buy |
|
|||||
|
2021
Q2 | $980K | Buy |
|
|||||
|
2021
Q1 | $965K | Buy |
|
|||||
|
2020
Q4 | $277K | Buy |
|
|||||
|
2020
Q3 | $111K | Sell |
|
|||||
|
2020
Q2 | $133K | Buy |
|
|||||
|
2020
Q1 | $81K | Sell |
|
|||||
|
2019
Q4 | $158K | Buy |
|
|||||
|
2019
Q3 | $67K | Hold |
|
|||||
|
2019
Q2 | $85K | Buy |
|
|||||
|
2019
Q1 | $84K | Buy |
|
|||||
|
2018
Q4 | $58K | Buy |
|
|||||
|
2018
Q3 | $78K | Hold |
|
|||||
|
2018
Q2 | $62K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $4K | Hold |
|
|||||
|
2016
Q4 | $12K | Buy |
|